Frederick “Fred” Frank, legendary investment banker and biotech giant who reshaped the structure of the biopharma industry by brokering such influential deals as Roche’s initial purchase of Genentech stock in 1990, passed away over the weekend.
PureTech CEO Daphne Zohar first shared the news of Frank’s death on Twitter. He was 89.
Over close to six decades steeped in pharmaceuticals and life sciences, Frank had assembled an unrivaled Rolodex and industry lore — and is himself the subject of many stories. A tough negotiator with a warm personality and a playful side, he got to know leaders of the top drugmakers as he played a crucial, if often hidden, role in the M&A.
Article From & Read More ( BREAKING: Data do not support widespread Covid vaccine boosters right now, outgoing FDA leaders write in the Lancet - Endpoints News )https://ift.tt/3C7yoiT
Health
Bagikan Berita Ini
0 Response to "BREAKING: Data do not support widespread Covid vaccine boosters right now, outgoing FDA leaders write in the Lancet - Endpoints News"
Post a Comment